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The Notch Signaling Pathway drives astrogliogenesis by regulating the
expression of the transcription factors NFIA and Sox9.
Derek Janssens · Dr. Merritt Taylor

Abstract: In the developing nervous system the Notch signaling pathway has recently been
shown to be necessary and sufficient for neural stem cells to differentiate into astroctyes, a
process called astrogliogenesis. However, the mechanism of how Notch signaling regulates this
process has not yet been characterized. Our lab is examining whether Notch signaling controls
the expression of the genes NFIA and Sox9 which are known to regulate astogliogenesis. These
candidate genes were selected because their DNA sequences have characteristics that indicate
their expression could be controlled by Notch through a transcriptional complex of Notch and
other proteins, including the DNA binding protein RBP/J. We developed a low-cost, effective
method of qPCR to study the relative abundance of gene expression in mice that underwent
selective deletion of the RBP/J gene in neural progenitors (including neural stem cells). We
found that disrupting Notch signaling in neural progenitors of the developing central nervous
system caused a significant decrease in both NFIA and Sox9 mRNA expression. In order to
ensure that this trend was reflected at the protein level we performed fluorescence microscopy
utilizing antibodies targeting the NFIA protein. To determine if Notch directly regulates NFIA
and Sox9 expression we are currently optimizing a Chromatin immuno-Precipitation assay to
establish whether the Notch-RBP/J transcriptional complex binds to the NFIA and Sox9 promoter
regions that are important to drive their expression. These novel findings offer insight into this
putative signaling pathway, advancing our understanding of how neural stem cell differentiation
is regulated.
Keywords: Gliogenesis, Notch Signaling Pathway, NFIA, Sox9, qPCR home-mix.
Introduction:
During development neural progenitors, including neural stem cells, are capable of dividing
and maturing, or differentiating, into the variety of cells that make up an organism. An important
question in stem cell biology is how these cells coordinate the differentiation and development of
tissues and organ systems at precisely the right time and place. In the developing central nervous
system (CNS) neural stem cells (NSCs) are responsible for giving rise to several kinds of specialized
tissue including neurons, and glia or astrocytes (a specific type of glia). During the early stages of the
formation of the CNS neural stem cells reside mainly in the ventricular zone and preferentially give
birth to neurons (neurogenesis). As development progresses these stem cells begin to undergo glialfate specification and migrate outward, predominantly giving rise to glia (gliogenesis). The Notch
signaling pathway is known to have multiple critical roles in the regulation of NSCs throughout this

neurogenic to gliogenic “switch.” The Notch receptor, which spans the plasma membrane, is
activated by ligands such as Delta 1. Upon ligand binding, an inner cellular fragment of the receptor
known as the Notch intercellular domain (NICD) is cleaved and translocates to the nucleus where it
binds to its transcriptional cofactor RBP/J (a DNA binding protein). The Notch-RBP/J complex then
binds to the promoter region of a variety of different genes and drives their expression. Prior to and
during neurogenesis the Notch signaling pathway functions to regulate stem cell maintenance by
directly regulating the expression of Hes transcriptional repressor genes (Ohtsuka et al. 1999). The
Hes genes inhibit proneural genes such as neurogenins (reviewed in Louvi and Artavanis-Tsakonas,
2006 ) and allow NSCs to undergo asymmetric division, simultaneously giving rise to neurons as
well as more NSCs. Conversely, later in development the Notch signaling pathway is both necessary
and sufficient to promote NSC differentiation into astroctyes and peripheral glia in the central and
peripheral nervous systems (Taylor et al. 2007, Morrison et al. 2000). The mechanism of how Notch
regulates this process has not yet been characterized. Although the up-regulation of the Hes genes
has been shown to promote gliogenesis in the retina (Hojo et al. 2000), similar experiments
examining the role of Hes 1 and Hes 5 in the developing spinal cord found that the misexpression of
these genes alone is not sufficient to promote gliogenesis in the spinal cord (Ohtsuka et al. 2001).
This indicates that Notch regulates the expression of an alternative astrogliogenic gene in the
developing CNS.
In order to address this issue we compiled a list of genes known to be involved in the
regulation of astrogliogenesis. The transcription factor NFIA has been shown to promote glial-fate
specification in the ventricular zone during early astrogliogenesis, and to promote the terminal
differentiation of progenitors into astrocytes later in development (Deneen et al. 2006), the loss of
NFIA expression has been shown to result in a loss of glial cells in the ventricular zone (Deneen et
al. 2006) similar to results seen when Notch signaling is disrupted just prior to astrogliogenesis
(Taylor et al., 2007). These observations suggest that NFIA could be a novel effector of Notch
regulated gliogenesis. A second transcription factor Sox9 is also necessary for astrogliogenesis in the
CNS and functions to regulate the proper timing of glial differentiation (Stolt, et al. 2003). Loss-offunction studies have shown that disrupting Notch signaling in neural progenitors results in a loss of
Sox9 expression (Taylor et al. 2007). However, it was not shown whether Notch regulates Sox9 gene
directly. We sought to define a more complete expression profile of Sox9 in order to establish if it is
indeed directly regulated by the Notch signaling pathway. Using a bio-informatic approach we
identified putative binding sites of the Notch-RBP/J complex on the promoter region of both NFIA
and Sox9. This information establishes the possibility of a direct link between Notch signaling and
these two astrogliogenic genes.
To determine if Notch signaling is necessary for NFIA and Sox9 expression, we conditionally
deleted Rbpsuh from NSC in the developing nervous system in mice. To assay the gene expression in
the mutant mice, we developed a low-cost effective approach using quantitative PCR to measure mRNA
expression, and standard immunohistochemical techniques for protein expression. We found that
disruption of Notch signaling by deletion of the Rbpsuh gene significantly decreased the expression of
the proastrocyte genes NF1A and Sox9. Thus these genes are likely effectors of Notch signaling known
to regulate astrogliogenesis.

Materials and Methods
Mice
Mice were housed in the animal facilities at Grand Valley State University. The care and treatment of
these animals followed those outlined in Application for Animal Use in Research or Teaching and
were approved by the Grand Valley State University’s Institutional Animal Care and Use Committee
(IACUC). All animals used in this study were genotyped with PCR on genomic DNA to verify

whether tissue samples contained the Rbpsuh gene deletion. The Cre insert gene was amplified using
forward primer ATTGCTGTCACTTGGTCGTGG and reverse primer
GAAAATGCTTCTGTCCGTTTGC. In Nestin-Cre tissue this reaction yields a 210 bp product. For
detection of the wild type Rbpsuh (Rbpsuh wt) allele reactions contained forward primer
GTTCTTAACCTGTTGGTCGGA and reverse primer GCTTGAGGCTTGATGTTCTGTAATGC
yielding a 487 bp PCR product. To detect the Rbpsuh floxed (Rbpsuh fl) inserts on the Rbpsuh allele
the forward primer GCAATCCATCTGTTCAATGGCC and reverse primer
GAAGGTCGGTTGACACCAGATAGC were used, these primers yield a 598bp product. Samples in
which the PCR reactions were positive for Nestin-Cre and showed that both Rbpsuh alleles were
floxed (Rbpsuh fl/fl) qualified as Rbpsuh cKO tissue. Tissue samples extracted from animals of all
other genotypes were used as control tissue: the Cre insert alone, Rbpsuh fl/fl alone, or Cre insert
along with the Rbpsuh fl/wt heterozygote have never been observed to deviate from the wild type
phenotype.
Total RNA Isolation and cDNA Generation
Tissue was obtained from the developing nervous system at a variety of different developmental time
points from both Nes-Cre+ Rbpsuh fl/fl mice and wild type mice. This tissue was then dissociated and
a cell count was determined using a hemocytometer. 18,000 to 90,000 cells of the extracted tissue
was then added to TriZol and stored at -800 C. Once thawed, glycogen was added to the TriZol before
separating the solution into an aqueous and organic layer in order to increase the yield of RNA.
Chloroform was then added to the solution and it was centrifuged at 10,500 rpm for 15min at -40 C.
The top aqueous layer was then transferred to an RNase free microcentrifuge tube and 500 L of
Isopropanol was added to precipitate the RNA. The solution was centrifuged at 10,500 rpm for 15
minutes at -40 C and the supernatant was removed. The RNA pellet was then washed with 1000 L of
80% ice cold ethanol and centrifuged again at 8,500 rpm for 15 minutes at -40 C. Again the
supernatant was removed and the pellet was allowed to air dry. The RNA was then resuspended in
Nuclease free H2O and treated with RQ-1 RNase-Free DNase (Promega, Madison, WI). 80 units of
RNaseOUT™ Recombinant Ribonuclease Inhibitor (Invitrogen). RNA clean up was preformed using
an RNeasy Mini Kit (Qiagen) following manufacturer’s specifications with two exeptions (1) the
initial flow-through of the RLT-BME-Ethanol buffer was saved and run through the column a second
time, and (2) a second 30 L of H2O was added to the column to increase the RNA elution yield.
The total RNA was then treated with random primers and Multiscribe Reverse Transcriptase
(Applied Biosystems) in order to generate cDNA. This solution was diluted in H20 to a concentration
of 100 cells/ L to be used for qPCR. All cDNA solutions were stored at -200C.
Quantitative Polymerase Chain Reaction
A low cost effective qPCR mix was developed. Our final reaction mix consisted of 0.15 L or 0.75
Units of HotStar Taq Plus DNA Polymerase (Qiagen), 2 L 10X Hot start buffer containing 15mM
MgCl2, 2 L of solution containing 10mM each dNTP, 2.4 L of 25 mM MgCl2, 1 L SYBR green
I (Invitrogen) working stock prepared by a dilution series of 1:100 in DMSO then 1:50 in H20 (final
dilution of 1:100,000). 2 L of 5uM Forward primer solution and 2 L of 5 M Reverse primer
solution were added to the reaction mix along with 2 L of cDNA solution (100cells / L), the
appropriate amount of H20 was then added for a final reaction volume of 20 L. Optical 8X tube
strips were used with Optical 8X cap strips (Stratagene). Initial denaturation was carried out at 950 C
for 5 minutes, followed by 40 cycles of 950 C for 30seconds, 580C for 30seconds, and 720 C for
30seconds. A dissociation curve was run following each reaction. The NFIA gene was amplified
using the forward primer AAGCCTCCAACCACATCAAC and the reverse primer
TTTACAAAGCTTGGATCCCG, this reaction amplifies a product 124 base pairs in length. The
Sox9 gene was amplified using the forward primer AGGAAGCTGGCAGACCAGT and the reverse

primer CGAAGGGTCTCTTCTCGCT, this reaction amplifies a product 102 base pairs in length. actin was used as the normalizer gene and was amplified with the forward primer
GATATCGCTGCGCTGGTCGTC and the reverse primer TCTCTTGCTCTGGGCCTCGTCAC,
this reaction produces a 176 bp product. The efficiency of these reactions was tested using a cDNA
serial dilution and determined to be within the acceptable range 90-110%. All reactions were carried
out using the Mx3000p qPCR machine (Stratagene).
Immunohistochemistry and tissue preparation
The spinal cords of e18.5 embryos were dissected and fixed in 4% paraformaldehyde overnight. The
fixed neural tissue was then washed in PBS, cryoprotected in 15% sucrose, and mounted in TissueTek OCT (VWR, West Chester, PA) prior to snap-freezing and sectioning into 12 m sections.
Tissue sections were collected using a Leica cryostat and mounted on glass slides. Tissue slides were
stored at -800C.
Tissue sections were blocked in modified GSS (PBS containing 5% goat serum and 0.5%
Triton X-100). The primary antibody targeting NFIA, NF-1A pAb (Active Motif), was diluted
1:2000 in modified GSS and applied to the neural tissue slide followed by a cover slip. This was
allowed to incubate overnight at 40 C. The tissue sections were then washed and a diluted 1:500 of
Cy3 goat anti rabbit antibody (Jackson Immunoresearch, Baltimore) was applied and incubated for 1
hour at room temperature. Nuclei were counterstained with 2.5 g/ml DAPI for 10 minutes at room
temperature and then mounted using ProLong antifade solution (Molecular Probes, Eugene, OR).

Results
To determine if Notch signaling is necessary for NFIA and Sox9 expression the first step was
to establish if disrupting Notch signaling causes a loss of NFIA expression. The complete loss-offunction of Notch signaling, such as in the case of Notch1 or Rbpsuh deletion, results in premature
neural differentiation and depletion of the progenitor pool (Lutof et al., 2002) prior to the onset of
astrogliogenesis. This makes these animals unsuitable for investigating the role of Notch signaling in
both the early and late stages of astrocyte differentiation. To circumvent this issue we used a Crerecombinase-LoxP conditional gene deletion approach in mice. Mutant mice (described as Rbpsuh
cKO or Rbpsuh conditional knockout mice) express Cre recombinase under a Nestin promoter,
which drives expression of Cre recombinase in neural stem cells in the developing central nervous
system. These mutant mice also have recognition sites for Cre recombinase engineered in the exons
for the gene Rbpsuh, which encodes the RBP/J protein. When Cre recombinase is expressed in
NSCs of Rbpsuh cKO mice, it excises the Rbpsuh gene so that it can no longer be expressed and
disrupts the formation of the Notch transcriptional complex and Notch signaling. Gene deletion in
NSCs occurs shortly before astrogliogenesis begins, thus blocking all canonical Notch signaling in
these NSCs, and rendering them unable to undergo astrogliogenesis (Taylor et al., 2007).
We used the quatitative Polymerase Chain Reaction (qPCR) to compare the relative abundance of
NFIA and Sox9 gene expression in the Rbpsuh cKO mice to control littermates. We found that the
conditional deletion of the gene Rbpsuh from NSCs of the CNS results in a decrease in the amount of
NFIA and Sox9 expression at all stages of astrogliogenesis. The data obtained from qPCR shows that at
E14.5 NFIA expression is 60% that of the control (sd 12%). At E15.5 the expression of NFIA in cKO
mice is 19.15% that of the control (sd 0.46%) and at E.19.5 NFIA expression is 42.5 % that of the control
(sd 4.95%). In the Rbpsuh cKO mice Sox9 expression is 49% that of the control (sd 3%). At E15.5 it is
12.30% that of the control (sd 0.99%) and at E 19.5 Sox9 expression is 38.5 % of the control (sd 3.54%)
(Figure 1). The results obtained from the qPCR analysis of Sox9 expression at early stages of
astrogliogenesis in Rbpsuh cKO mice where consistent with previous findings (Taylor et al. 2007).

Figure 1: The conditional KO of RBP/J
in NSC results in a decrease in the
relative abundance of both NFIA and
Sox9 mRNA expression in the
developing CNS
(A) qPCR analysis of NFIA mRNA
expression in developing neural tube of
Rbpsuh cKO mice as compared to the
control. Three different stages of
astrogliogenesis were assessed
(Early = E14.5, Middle = E15.5 and
Late = E19.5) N = 2 for all stages of
astrogliogenesis.
(B) qPCR analysis of Sox9 mRNA
expression in developing neural tube of
Rbpsuh cKO mice as compared to the
control. Three different stages of
astrogliogenesis were assessed
(Early = E14.5, Middle = E15.5 and
Late = E19.5) N=2 for all stages of
astrogliogenesis.
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Rbpsuh cKO mice then in the
control mice. As expected in the
control condition cells staining
positive for NFIA were
concentrated in the regions in
which astocytes arise, dorsal to
the ventricular zone surrounding
the neural tube and radiating
outward from this position to
both the left and right ventral
horns of the CNS. In the spinal
cords of the cKO mice there is a
striking decrease in the number

Control

Rbpsuh cKO

NFIA Protein
expression

The immunofluorescence assay
of NFIA protein expression
showed that at E18.5 fewer
cells expressed NFIA in the

Figure 2: The conditional KO of RBP/J in NSCs results in a
decrease in the relative abundance of NFIA protein expression
primarily in the regions surrounding the neural tube. These
images show a transverse cross section of the E18.5 developing
spinal cord stained with an antibody targeting NFIA.

of cells that are brightly stained for NFIA in the region surrounding the neural tube (which has
collapsed, a trait common to this model) as well as the ventral regions of the CNS (Figure 2).
We found that blocking Notch signaling results in a significant decrease of both NFIA and
Sox9 expression in the developing CNS at all stages of astrogliogenesis prior to birth. Pups born with
this mutation die at birth, so later time-points could not be tested.
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Figure 3: Various models explaining the regulation
of the neurogenic to gliogenic “switch” in NSCs.
(A) Notch regulates the maintenance of the NSCs
(S) and inhibits the formation of neurons (N) by
promoting Hes 5. Notch drives the differentiation
of NSCs into glia (G) through an unknown
mechanism.
(B) Both Notch and NFIA are necessary for Hes 5
expression and NFIA drives gliogenesis.
(C) Notch regulates Hes5 directly and indirectly
due to its necessity for NFIA, and promotes
gliogenesis through the regulation of NFIA either
directly or indirectly.
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Discussion
These findings indicate that Notch signaling is necessary for the expression of both NFIA and
Sox9 at multiple stages of astrogliogenesis in the developing CNS (Figs. 1 & 2), unveiling a new
function of the Notch signaling pathway. However, it is not know whether Notch directly or
indirectly regulates the expression of these genes. Notch could regulate a signaling cascade which in
turn regulates NFIA and Sox9 expression. We are currently performing a Chromatin Immunoprecipitation assay to determine if the Notch-RBP/J complex directly drives NFIA and Sox9
expression by binding to the promoter region of these genes at sites identified by our bioinfomatic
approach. These ongoing experiments will determine how Notch regulates these astrogliogenic
genes.
The results of this study provide evidence in support of a unitary mechanism that regulates
the neurogenic to gliogenic “switch” of NSCs in developing spinal cord. Currently two separate
theories of how this process is regulated exist. The first is that developing neuroblasts present Notch
ligand feedback signals that activate Notch signaling in the surrounding NSCs and promote
differentiation into glia (Morrison et al. 2000). This theory garnered support from the finding that

disruption of Notch signaling “in vivo” results in a severe defect of astrogliogenesis (Taylor et al.,
2007) indicating that Notch is both necessary and sufficient for glial differentiation (Figure 3 (A)). A
second explanation is that the Notch signaling pathway and its effectors function to suppress
neurogenesis, while the NFIA gene, in conjunction with another transcription factor NFIB, promote
glia-fate specification (Deneen et al., 2006). Interestingly, it has been found that NFIA is also
required for the inhibition of neurogenesis due to its necessity for the maintenance of the Notch
effector Hes5 (Deneen et al. 2006) (Figure 3 (B)). While these two explanations of the “switch” of
NSCs to glial lineages could exist contemporaneously, our data suggest that they are in the same
pathway (Figure 3 (C)).
These findings may also yield insight into several pathologies that afflict the nervous system
including multiple sclerosis, and the glial scarring that is associated with damage to the spinal cord.
Both of these pathologies have been linked to an astrocyte hypertrophy (John et al., 2002, Ridet et al
1997) making the Notch signaling pathway and its effectors potential targets for novel therapies.
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